MENU
AGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Agenus (AGEN) Earnings Date & Reports
Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
AGEN is expected to report earnings to fall 200.00% to 0 cents per share on November 09
Q3'26
Est.
$0.01
Q2'26
Missed
by $0.07
Q1'26
Beat
by $1.67
Q4'25
Missed
by $0.04
Q3'25
Beat
by $2.22
The last earnings report on August 06 showed earnings per share of 0 cents, missing the estimate of 5 cents. With 241.99K shares outstanding, the current market capitalization sits at 289.04M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a developer of technologies to treat cancers and infectious diseases
Industry Biotechnology
Industry
Biotechnology
Address
3 Forbes Road
Phone
+1 781 674-4400
Employees
81
Web
https://www.agenusbio.com